Equity Trades portfolio renamed Medical Profits; Three new biotech stocks added: RWLK, EKSO, PH

By Jim Pearce • June 22, 2015

As much as we loved the idea of making trading recommendations based on short term opportunities we saw in the tech sector, the feedback we got from our subscribers is that they would prefer a longer term, and more focused portfolio. For that reason, we are renaming our Equity Trades portfolio “Medical Profits” to reflect our recently initiated coverage of the biotech sector. Also, we are adding three new stocks to the Medical Profits Portfolio, as follows:

ReWalk Robotics (RWLK), buy limit = $15/stop loss = $9
Ekso Bionics (EKSO), buy limit = $2.10/stop loss = $1.15
Parker-Hannifin (PH), buy limit = $130/stop loss = $105

A complete explanation of these actions can be found in the June 22, 2015 edition of Smart Tech 50 Weekly Movers.

Stock Talk

Comments Oldest First

Comments Guidelines

BMOFI48

10/27/16 ‐ 10:28am ET October 27, 2016 at 10:28am ET

Jim–What are your thoughts on ReWalk’s latest decision to sell shares and warrants? Is this good for those of us that bought on your earlier recommendation, or time to say bye? Bruce

Jim Pearce

10/27/16 ‐ 4:51pm ET October 27, 2016 at 4:51pm ET

From what I can see, there isn’t much good news in this development other than RWLK having enough capital to remain in business long enough to come up with a better marketing strategy: “The company intends to use the net proceeds of the offering for general corporate purposes, including supporting its ongoing sales, marketing and reimbursement efforts to grow its business and funding research and development activities focused on product development.” Of the two small exoskeleton stocks originally recommended, it appears EKSO has gained the upper hand over the past year so you may want to switch into that one if you don’t own it already (btw, its up nearly 12% today so moving in the opposite direction of RWLK).

Strat

10/28/16 ‐ 11:33am ET October 28, 2016 at 11:33am ET

what about the lawsuits against RWLK? what if you have more than $20K in each stock RWLK and Ekso ?

Jim Pearce

10/28/16 ‐ 1:04pm ET October 28, 2016 at 1:04pm ET

As a publisher we are prohibited from giving personalized advice, so I will make this general observation instead. When we initiated this position 16 months ago we recommended both of these stocks since we couldn’t tell at that time which one had the upper hand. But now that it appears EKSO is pulling away from RWLK, I’d be inclined to take what I had in RWLK and move it into EKSO. btw, EKSO announces its quarterly results (and forward guidance) on November 9th, which may explain why its share price has been moving higher over the past couple of days.

Add New Comments

You must be logged in to post to Stock Talk OR create an account